Time series analysis revealed prognostic value of continuous nasopharyngeal SARS-CoV-2 nucleic acid quantification for COVID-19: A retrospective study of >3,000 COVID-19 patients from 2 centers
Zhiyuan Wu,Can Yang,Yutao Shen,Qingyun Zhang,Xuemei Tang,Di Wang,Yu Xu,Guojun Cao,Xiaodong Song,Yanchun Ma,Huajie Fan,Hailong Lu,Yaju Li,Xiangyu Li,Yiqin Shen,Chen Zhang,Min Zhu,Xiaoyan Teng,Yuzhen Du,Ming Guan
DOI: https://doi.org/10.1016/j.cca.2023.117227
IF: 6.314
2023-01-13
Clinica Chimica Acta
Abstract:Background Early stratification of disease progression remains one of the major challenges towards the post-coronavirus disease 2019 (COVID-19) era. The clinical relevance of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) nucleic acid load is debated due to the heterogeneity in patients' underlying health conditions. We determined the prognostic value of nasopharyngeal viral load dynamic conversion for COVID-19. Methods The cycling threshold (Ct) values of 28,937 nasopharyngeal SARS-CoV-2 RT-PCRs were retrospectively collected from 3,364 COVID-19 patients during hospitalization and coordinated to the onset of disease progression. The ROC curve was utilized to determine the predictive performance of the rate of Ct value alteration between two consecutive RT-PCR runs within 48 h (ΔCt%) for disease transformation across patients with different COVID-19 severity and immune backgrounds, and further validated with 1,860 SARS-CoV-2 RT-PCR results from an independent validation cohort of 262 patients. For the 67 patients with severe COVID-19, Kaplan-Meier analysis was performed to evaluate the difference in survival between patients stratified by the magnitude of Ct value alteration between the late and early stages of hospitalization. Results The kinetics of viral nucleic acid conversion diversified across COVID-19 patients with different clinical characteristics and disease severities. The ΔCt% is a clinical characteristic- and host immune status-independent indicator for COVID-19 progression prediction (AUC = 0.79, 95% CI = 0.76 to 0.81), which outperformed the canonical blood test markers, including c-reactive protein (AUC = 0.57, 95% CI = 0.53 to 0.61), serum amyloid A (AUC = 0.61, 95% CI = 0.54 to 0.68), lactate dehydrogenase (AUC = 0.61, 95% CI = 0.56 to 0.67), D-dimer (AUC = 0.56, 95% CI = 0.46 to 0.66), and lymphocyte count (AUC = 0.62, 95% CI = 0.58 to 0.66). Patients with persistent high SARS-CoV-2 viral load (an increase of mean Ct value < 50%) during the first 3 days of hospitalization demonstrated a significantly unfavorable survival (HR = 0.16, 95% CI = 0.04 to 0.65, P = 2.41×10-3). Conclusions Viral nucleic acid dynamics of SARS-CoV-2 eliminates the inter-patient variance of basic health conditions and therefore, can serve as a prognostic marker for COVID-19.
medical laboratory technology